Ymd. Lo et al., Molecular prognostication of nasopharyngeal carcinoma by quantitative analysis of circulating Epstein-Barr virus DNA, CANCER RES, 60(24), 2000, pp. 6878-6881
We investigated the prognostic implication of pretreatment plasma/serum EBV
DNA concentration, as measured by real-time quantitative PCR, in nasophary
ngeal carcinoma (NPC), In 91 prospectively recruited NPC patients, those wi
th recurrence or metastasis within the first year after treatment had a hig
her median plasma EBV DNA concentration than those without events (41,756 c
opies/ml versus 5,807 copies/ml; P < 0.001, Mann-Whitney rank-sum test). In
multivariate logistic regression analysis, plasma EBV DNA was an independe
nt prognostic indicator for early clinical events [relative risk = 3.8 (95%
confidence interval, 1.6-9.2 for each 10-fold increase in plasma EBV DNA c
oncentration; P = 0.003)], In a second cohort of 139 NPC patients followed-
up for a median period of 2,027 days (interquartile range, 597-2,335 days),
serum EBV DNA was found to be a significant variable associated with NPC-r
elated death in multivariate Cox's regression analysis [relative risk = 1.6
(95% confidence interval, 1.1-2.1 for each 10-fold increase in serum EBV D
NA concentration; P = 0.007)]. The quantitation of circulating EBV DNA may
thus allow improved prognostication of NPC.